Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01784341 · ClinicalTrials.gov registry record

Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?

A clinical trial of Bipolar Disorder, sponsored by Northwestern University.

Completed
Registry status
10
Enrollment target
1
Study location

NCT01784341: Completed study of Bipolar Disorder, sponsored by Northwestern University.

NCT01784341 is a study of Bipolar Disorder that has completed, run by Northwestern University. The registered enrollment target is 10 participants, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01784341, a study of Bipolar Disorder, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

The overall aim of this project is to compare sleep patterns and melatonin profiles in individuals with bipolar disorder during depression and after remission. The hypothesis is that sleep time, rest-activity cycles and melatonin onset will be delayed during depression and become less delayed after remission.

Primary Outcome

Subjects will be instructed in the procedures used for home-based, self-collection of saliva samples. The protocol developed by Sit and colleagues at the University of Pittsburgh (attached), will be used. This involves obtaining ten saliva samples, one every 30 minutes, over a 4.5 hour period. This protocol contains instructions about ambient lighting, posture, exercise, eating, and use of the oral swabs and collection kits.

Conditions Studied

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2011-08
Est. Completion 2016-12
Northwestern University

1,209 total trials

What the finished NCT01784341 record still lists

NCT01784341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT01784341 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01784341 about?

NCT01784341 is a clinical study titled "Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?". The overall aim of this project is to compare sleep patterns and melatonin profiles in individuals with bipolar disorder during depression and after remission. The hypothesis is that sleep time, rest-activity cycles and melatonin onset will be delayed during depression and become less delayed after ...

What is the current status of trial NCT01784341?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2011-08. Estimated completion is 2016-12.

What conditions does trial NCT01784341 study?

This clinical trial studies the following conditions: Bipolar Disorder.

Who is sponsoring clinical trial NCT01784341?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01784341 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01784341's enrollment target sits among peer trials

10 161st of 162 higher than 2 of 162 other Bipolar Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01784341, the US trial registry maintained by the National Library of Medicine. NCT01784341 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.